T1	Participants 82 101	Parkinson's disease
T2	Participants 256 289	patients with Parkinson's disease
T3	Participants 323 427	10 patients with a moderate motor impairment insufficiently controlled by monotherapy with bromocriptine
T4	Participants 462 476	eight patients
